Back

Insights and lessons from the ODYSSEY outcomes trial: which patients benefit most?

31 August 2019 (15:35 - 15:50)
Organised by:
Congress Presentation Part of: PCSK9i, changing practice in cardiology: the emerging story Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

4 More presentations in this session

Presentation thumbnail
Introduction
Professor J. Chapman (Paris, FR)
Slides Video
Presentation thumbnail
Extending the evidence: what did the FOURIER trial learns us on managing high risk patients?
Professor M. Sabatine (Boston, US)
Slides Video
Presentation thumbnail
Targeting PCSK9: expanding knowledge and targeting new frontiers
Professor J. Kastelein (Amsterdam, NL)
Video
Presentation thumbnail
Discussion
Professor J. Chapman (Paris, FR) Professor J. Kastelein (Amsterdam, NL)
Slides Video

Access the full session

Session thumbnail
PCSK9i, changing practice in cardiology: the emerging story

The Event

Event poster

ESC Congress 2019

31 August 2019 15:35 CET